CpG Oligodeoxynucleotides for Anticancer Monotherapy from Preclinical Stages to Clinical Trials.

Zhang, Zhongkun; Kuo, Jimmy Chun-Tien; Yao, Siyu; Zhang, Chi; Khan, Hira; Lee, Robert J

Zhang, Zhongkun; Kuo, Jimmy Chun-Tien; Yao, Siyu; Zhang, Chi; Khan, Hira; Lee, Robert J.

Afiliação

Zhang Z; Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, 500 W 12th Avenue, Columbus, OH 43210, USA.
Kuo JC; Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, 500 W 12th Avenue, Columbus, OH 43210, USA.
Yao S; Department of Food Science and Technology, The Ohio State University, 110 Parker Food Science and Technology Building, 2015 Fyffe Road, Columbus, OH 43210, USA.
Zhang C; Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, 500 W 12th Avenue, Columbus, OH 43210, USA.
Khan H; Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, 500 W 12th Avenue, Columbus, OH 43210, USA.
Lee RJ; Department of Pharmacy, Abbottabad University of Science and Technology, Havelian, Abbottabad 22500, Pakistan.

Pharmaceutics ; 14(1)2021 Dec 28.

Article em En | MEDLINE | ID: mdl-35056969

Palavras-chave

CpG oligonucleotide; immunotherapy; toll-like receptor 9

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Pharmaceutics Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos